Tag Archives: prognostic test

October, 2018

17 October
Castle Biosciences’ Cutaneous Squamous Cell Carcinoma Prognostic Test Development Progress Highlighted at Dermatology Meeting

FRIENDSWOOD, Texas–(BUSINESS WIRE)–Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer management decisions, today announced the presentation of data demonstrating progress in the development of a prognostic gene expression profile test for cutaneous squamous cell carcinoma (cSCC), one of the most common types of cancer. …
Share

12 October
A Common Nerve Protein Elevated in Aggressive Neuroblastomas

WASHINGTON – A protein produced by nerve cells appears to be elevated in the blood of those with an aggressive form of neuroblastoma. The finding, published online October 12 in the American Journal of Pathology, could potentially lead to a prognostic test for the disease or be used to monitor …
Share

19 October
Metamark’s Novel Prognostic Test Demonstrates Potential to be Cost-Effective for Management of Prostate Cancer

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Metamark Genetics, Inc. (“Metamark” or the “Company”), a leader in commercializing high-value urologic oncology products, today announced that a study published in The Oncologist demonstrates that use of its novel proteomic prognostic test ProMark®, for early-stage prostate cancer, is likely to result in more cost-effective care than the National …
Share